Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL969368 | 0.94 | KDM4E (0.40) | KDM4EALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL1006797 | 0.92 | KDM4E (0.39) | KDM4EALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL988884 | 0.92 | KDM4E (0.39) | KDM4EALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL1006580 | 0.92 | KDM4E (0.39) | KDM4EALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL1054886 | 0.87 | KDM4E (0.43) | KDM4EALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL1975023 | 0.87 | KDM4E (0.46) | KDM4EALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL19689468 | 0.87 | KDM4E (0.46) | KDM4EALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL4445579 | 0.85 | KDM4E (0.44) | KDM4EALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL30996063 | 0.85 | KDM4E (0.44) | KDM4EALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL1012047 | 0.82 | KDM4E (0.48) | KDM4EALDH1A1TSHRMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260071019-A1 | NORBORNENE-DERIVED COPOLYMER, MANUFACTURING METHOD THEREOF AND METHOD FOR USING THE SAME | CPC CORP TAIWAN (TW) | 2026-03-12 | — | — | US | claimed |
| EP-4638569-A1 | SUPPORTED MEMBRANES BY THERMAL AND UV INITIATED MASS POLYMERIZATION | Promerus, LLC (US) | 2025-10-29 | — | — | EP | claimed |
| US-20250177927-A1 | SUPPORTED MEMBRANES BY THERMAL AND UV INITITATED MASS POLYMERIZATION | PROMERUS, LLC (US) | 2025-06-05 | — | — | US | claimed |
| US-12251668-B2 | Supported membranes by thermal and UV initiated mass polymerization | PROMERUS, LLC (US) | 2025-03-18 | — | — | US | claimed |
| US-20240216875-A1 | SUPPORTED MEMBRANES BY THERMAL AND UV INITITATED MASS POLYMERIZATION | PROMERUS, LLC (US) | 2024-07-04 | — | — | US | claimed |
| WO-2024137739-A1 | SUPPORTED MEMBRANES BY THERMAL AND UV INITIATED MASS POLYMERIZATION | PROMERUS, LLC (US) | 2024-06-27 | — | — | WO | claimed |
| US-11879033-B2 | Polycyloolefinic polymers and anion exchange membranes derived therefrom | PROMERUS, LLC (US) | 2024-01-23 | — | — | US | claimed |
| EP-4247865-A1 | SOLUTION PROCESS FOR PRODUCTION OF HALIDE- OR TERTIARY AMINE- FUNCTIONALIZED POLYOLEFINS | SABIC Global Technologies B.V. (NL) | 2023-09-27 | — | — | EP | claimed |
| EP-4188980-A1 | POLYCYLOOLEFINIC POLYMERS AND ANION EXCHANGE MEMBRANES DERIVED THEREFROM | Promerus, LLC (US) | 2023-06-07 | — | — | EP | claimed |
| CN-116235324-A | Polycyclic olefin polymers and anion exchange membranes derived therefrom | 普罗米鲁斯有限责任公司 | 2023-06-06 | — | — | CN | claimed |
| WO-2022106688-A1 | SOLUTION PROCESS FOR PRODUCTION OF HALIDE- OR TERTIARY AMINE- FUNCTIONALIZED POLYOLEFINS | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2022-05-27 | — | — | WO | claimed |
| US-20220033571-A1 | POLYCYLOOLEFINIC POLYMERS AND ANION EXCHANGE MEMBRANES DERIVED THEREFROM | PROMERUS, LLC (US) | 2022-02-03 | — | — | US | claimed |
| WO-2022026794-A1 | POLYCYLOOLEFINIC POLYMERS AND ANION EXCHANGE MEMBRANES DERIVED THEREFROM | PROMERUS, LLC (US) | 2022-02-03 | — | — | WO | claimed |
| US-20260071019-A1 | NORBORNENE-DERIVED COPOLYMER, MANUFACTURING METHOD THEREOF AND METHOD FOR USING THE SAME | CPC CORP TAIWAN (TW) | 2026-03-12 | — | — | US | disclosed |
| US-20260071019-A1 | NORBORNENE-DERIVED COPOLYMER, MANUFACTURING METHOD THEREOF AND METHOD FOR USING THE SAME | CPC CORP TAIWAN (TW) | 2026-03-12 | — | — | US | disclosed |
| EP-4638569-A1 | SUPPORTED MEMBRANES BY THERMAL AND UV INITIATED MASS POLYMERIZATION | Promerus, LLC (US) | 2025-10-29 | — | — | EP | disclosed |
| US-20170207393-A1 | HOLE TRANSPORTING COMPOUNDS AND COMPOSITIONS | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2017-07-20 | — | — | US | disclosed |
| US-20170207394-A1 | HOLE TRANSPORTING CYCLOBUTENE COMPOUND | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2017-07-20 | — | — | US | disclosed |
| US-20110020731-A1 | POLYMER ELECTROLYTE COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-01-27 | — | — | US | disclosed |
| EP-2270104-A1 | POLYMER ELECTROLYTE COMPOSITION | Sumitomo Chemical Company, Limited (JP) | 2011-01-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260071019-A1 | NORBORNENE-DERIVED COPOLYMER, MANUFACTURING METHOD THEREOF AND METHOD FOR USING THE SAME | NTRK1, PBRM1, RPL8 | KDM4E 845/4885ALDH1A1 2286/4885TSHR 4218/4885 |
| US-20170207393-A1 | HOLE TRANSPORTING COMPOUNDS AND COMPOSITIONS | SP1, NR0B1, C1S | KDM4E 4323/4885ALDH1A1 622/4885TSHR 3085/4885 |
| US-20170207394-A1 | HOLE TRANSPORTING CYCLOBUTENE COMPOUND | SP1, NR0B1, CCNT1 | KDM4E 4476/4885ALDH1A1 1559/4885TSHR 2434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.